Annual Drug Patent Expirations for SUSTOL Sustol is a drug marketed by Heron Theraps Inc and is included in one NDA. It is available from one supplier. There are seven…
The post New patent expiration for Heron Theraps drug SUSTOL appeared first on Drug…

Annual Drug Patent Expirations for FERRIPROX Ferriprox is a drug marketed by Chiesi and is included in three NDAs. It is available from two suppliers. There are five patents protecting…
The post New patent expiration for Chiesi drug FERRIPROX appeared …

Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29 Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier. There are five…
The post New patent expiration for Palatin Te…

SEEBRI (glycopyrrolate) Novartis Patent: 9,962,338 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected] or visit…
The post Drug …

Annual Drug Patent Expirations for UTIBRON Utibron is a drug marketed by Novartis and is included in one NDA. There are thirteen patents protecting this drug. Drug patent litigation for…
The post New patent expiration for Novartis drug UTIBRON appeared…

UTIBRON (glycopyrrolate; indacaterol maleate) Novartis Patent: 8,956,661 Expiration: Jun 27, 2021 See More … For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact [email protected]…
T…

Annual Drug Patent Expirations for APTIOM Aptiom is a drug marketed by Sunovion Pharms Inc and is included in one NDA. It is available from one supplier. There are eleven…
The post New patent expiration for Sunovion Pharms drug APTIOM appeared first on…

Annual Drug Patent Expirations for SEEBRI Seebri is a drug marketed by Novartis and is included in one NDA. It is available from one supplier. There are twelve patents protecting…
The post New patent expiration for Novartis drug SEEBRI appeared first o…